Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Dumontet

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Presse Medicale (Paris, France : 1983)|December 5, 1987
[Use of monoclonal antibodies in the treatment of cancer]C Dumontet
Expert Opinion on Investigational Drugs|November 4, 2000
Mechanisms of action and resistance to tubulin-binding agentsC Dumontet
Journal De Chirurgie|December 1, 1989
[Immunotherapy and cancer: the role of monoclonal antibodies]C Dumontet
The Journal of Biological Chemistry|December 10, 1983
Identification, purification, and characterization of a non-heme lactoperoxidase in bovine milkC Dumontet, B Rousset
Bulletin Du Cancer|January 1, 1991
[Gangliosides and cancer]C Dumontet, J Portoukalian
Revue Des Maladies Respiratoires|April 21, 2010
[Class III beta tubulin expression in nonsmall cell lung cancer]P Sève, C Dumontet
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell deathC Dumontet, B I Sikic
Journal of Immunological Methods|August 7, 1997
Very low density lipoproteins and interleukin 2 enhance the immunogenicity of 9-O-acetyl-GD3 ganglioside in BALB/c miceC Dumontet, A Rebbaa, J Portoukalian
Biochemical and Biophysical Research Communications|December 30, 1992
Kinetics and organ distribution of [14C]-sialic acid-GM3 and [3H]-sphingosine-GM1 after intravenous injection in ratsC Dumontet, A Rebbaa, J Portoukalian
Leukemia|February 18, 2017
Monoclonal antibody therapy in multiple myelomaC Touzeau, P Moreau, C Dumontet
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Presse Medicale (Paris, France : 1983)|December 5, 1987
[Use of monoclonal antibodies in the treatment of cancer]C Dumontet
Expert Opinion on Investigational Drugs|November 4, 2000
Mechanisms of action and resistance to tubulin-binding agentsC Dumontet
Journal De Chirurgie|December 1, 1989
[Immunotherapy and cancer: the role of monoclonal antibodies]C Dumontet
The Journal of Biological Chemistry|December 10, 1983
Identification, purification, and characterization of a non-heme lactoperoxidase in bovine milkC Dumontet, B Rousset
Bulletin Du Cancer|January 1, 1991
[Gangliosides and cancer]C Dumontet, J Portoukalian
Revue Des Maladies Respiratoires|April 21, 2010
[Class III beta tubulin expression in nonsmall cell lung cancer]P Sève, C Dumontet
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell deathC Dumontet, B I Sikic
Journal of Immunological Methods|August 7, 1997
Very low density lipoproteins and interleukin 2 enhance the immunogenicity of 9-O-acetyl-GD3 ganglioside in BALB/c miceC Dumontet, A Rebbaa, J Portoukalian
Biochemical and Biophysical Research Communications|December 30, 1992
Kinetics and organ distribution of [14C]-sialic acid-GM3 and [3H]-sphingosine-GM1 after intravenous injection in ratsC Dumontet, A Rebbaa, J Portoukalian
Leukemia|February 18, 2017
Monoclonal antibody therapy in multiple myelomaC Touzeau, P Moreau, C Dumontet
Pageof 11